Screening for lung cancer and idiopathic pulmonary fibrosis: Killing two birds with one stone

Radiology

Volumn 270, Issue 2, 2014, Pages 630-631

  Cordier, Jean Francois ^a   Cottin, Vincent ^a   Khouatra, Chahera ^a   Revel, Didier ^b  

^a Department of Respiratory Medicine   (France)

^b Louis Pradel's Cardiovascular Hospital   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SCREENING; COMPUTER ASSISTED TOMOGRAPHY; CRACKLE; DISEASE ASSOCIATION; DISEASE COURSE; EARLY DIAGNOSIS; FIBROSING ALVEOLITIS; HUMAN; INTERSTITIAL PNEUMONIA; LETTER; LUNG AUSCULTATION; LUNG CANCER; LUNG FUNCTION TEST; PRIORITY JOURNAL; PROGNOSIS; SMOKING;

FEMALE; HUMANS; LUNG DISEASES, INTERSTITIAL; LUNG NEOPLASMS; MALE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84893442000     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.13131866     Document Type: Letter

References (5)

1. Jin GY, Lynch D, Chawla A, et al. Interstitial lung abnormalities in a CT lung cancer screening population: prevalence and progression rate. Radiology 2013;268(2):563-571.
2. King TE Jr, Pardo A, Selman M. Idiopathic pulmonary fibrosis. Lancet 2011;378(9807):1949-1961.
3. Noble PW, Alvera C, Bradford WZ, et al. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials. Lancet 2011;377(9779):1760-1769.
4. Richeldi L, Costabel U, Selman M, et al. Efficacy of tyrosine kinase inhibitor in idiopathic pulmonary fibrosis. N Engl J Med 2011;365(12):1079-1087.
5. Cordier JF, Cottin V. Neglected evidence in idiopathic pulmonary fibrosis: from history to earlier diagnosis. Eur Respir J 2013;42(4):916-923.